Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEIRAGTX HOLDINGS PLC

(MGTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo MeiraGTx Holdings plc
MeiraGTx Holdings plc is a clinical-stage gene therapy company. The Company develops gene therapy treatments for a range of inherited and acquired disorders. It is focused on developing therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia, radiation treatment for head and neck cancers and neurodegenerative diseases, such as amyothrophic lateral sclerosis (ALS). It is also developing transformative technology to enable the use of small molecules to turn gene therapy product candidates on and off. It is focused on three areas of unmet medical needs, including inherited retinal diseases, severe forms of xerostomia and neurodegenerative diseases. Its product candidates include AAV-CNGB3, AAV-CNGA3, AAV-RPGR, AAV-RPE65, AAV-AQP1 and AAV-UPF1.

Number of employees : 219 people.
Sales per Business
20192020Delta
Novel Gene Therapy Treatments13.29100%15.56100% +17.09%
USD in Million
Sales per region
20192020Delta
United Kingdom13.29100%15.56100% +17.09%
USD in Million
Managers
Name Title Age Since
Alexandria Forbes, Dr. President, Chief Executive Officer & Director 55 2015
Richard Giroux Chief Operating & Financial Officer 48 2019
Robert K. Zeldin, Dr. Chief Medical Officer 57 2020
Keith Reginald Harris, Dr. Chairman 67 2018
Ellen Hukkelhoven, Dr. Independent Director 33 2017
Arnold Jay Levine, Dr. Independent Director 80 2016
Joel Marcus Independent Director 72 2015
Neil Francis Jeremy Mendoza Independent Director 60 2015
Thomas Eugene Shenk, Dr. Independent Director 73 2015
Martin S. Indyk, Dr. Independent Director 68 2019
Members of the board
Name Title Age Since
Keith Reginald Harris, Dr. Chairman 67 2018
Alexandria Forbes, Dr. President, Chief Executive Officer & Director 55 2015
Ellen Hukkelhoven, Dr. Independent Director 33 2017
Arnold Jay Levine, Dr. Independent Director 80 2016
Joel Marcus Independent Director 72 2015
Neil Francis Jeremy Mendoza Independent Director 60 2015
Thomas Eugene Shenk, Dr. Independent Director 73 2015
Martin S. Indyk, Dr. Independent Director 68 2019
Nicole Seligman Independent Director 63 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 44,314,885 33,739,462 76.1% 0 0.0% 76.1%
Shareholders
NameEquities%
Perceptive Advisors LLC 6,948,277 15.7%
OrbiMed Advisors Private Equity 4,102,925 9.26%
Johnson & Johnson Innovation JJDC, Inc. 2,898,550 6.54%
OrbiMed Advisors LLC 2,457,930 5.55%
Adage Capital Management LP 2,200,000 4.96%
T. Rowe Price Associates, Inc. (Investment Management) 2,006,365 4.53%
Alexandria Real Estate Equities, Inc. 1,982,726 4.47%
Alexandria Forbes 1,290,781 2.91%
683 Capital Management LLC 1,289,709 2.91%
Richard Giroux 931,370 2.10%
Company contact information
MeiraGTx Holdings Plc
430 East 29th Street
14th floor
New York, NY 10016

Phone : +1.646.860.7985
Web : http://www.meiragtx.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of MeiraGTx Holdings plc
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
MEIRAGTX HOLDINGS PLC-5.68%633
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.12.71%232 621
ELI LILLY AND COMPANY40.89%215 657
MERCK & CO., INC.-4.24%198 283
ABBVIE INC.2.03%193 205
ASTRAZENECA PLC20.08%187 492
NOVARTIS AG-8.03%186 330
BRISTOL-MYERS SQUIBB COMPANY-5.92%129 683
SANOFI6.53%122 086
AMGEN INC.-9.60%118 022
GLAXOSMITHKLINE PLC4.29%96 396
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-27.49%57 462
BAYER AG-0.56%54 575
JIANGSU HENGRUI MEDICINE CO., LTD.-46.12%49 566
DAIICHI SANKYO COMPANY, LIMITED-16.76%49 400
TAKEDA PHARMACEUTICAL COMPANY LIMITED-13.93%44 517
ASTELLAS PHARMA INC.25.60%32 494